MedTrace Logo

The Effect of Cycled Light on Premature Infants and Mothers

NCT05010252 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2021-08-18

No results posted yet for this study

Summary

Irregular lighting and lack of light in premature infants will affect their health, produce negative effects such as physiological and visual development, and also affect the mother's sleep and quality of life. This study is to verify the effect and delay effect of two-week premature infants' light intervention on their physiological indicators and visual development, mother's sleep quality and quality of life.

It is planned to be in the Neonatal Moderate to Severe Ward of National Taiwan University Children's Hospital, and the subjects are premature babies born 32 weeks old. Divided into two groups of light intervention group and control group, longitudinal tracking intervention effect and six-week and three-month delay effect.

Conditions

  • Preterm Infant Development
  • Retinopathy of Prematurity
  • Sleep Quality
  • Quality of Life

Interventions

BEHAVIORAL

Cycled light Experimental

The preliminary plan of this study is to carry out empirical evidence and expert advice to confirm precise lighting and develop care intervention strategies for preterm infants based on evidence. It is planned to be in the Neonatal Intermediate Care Nursery, National Taiwan University Children's Hospital, and the subjects are premature babies born 32 weeks old. Divided into two groups of light intervention group and control group, longitudinal tracking intervention effect and six-weeks and three-months delay effect.

Sponsors & Collaborators

  • Taiwan Nurses Association

    collaborator OTHER

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Shin Fen Lee, Head Nurse · National Taiwan University Children Hospital

  • Ciao-Lin Ho, PhD · Second Degree Bachelor of Science in Nursing, College of Medicine, National Taiwan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
32 Weeks
Max Age
40 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-16
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05010252 on ClinicalTrials.gov